JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$2.01B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.93B |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$1.27B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$920M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$909M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.06B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$2.61B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.47B |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.26B |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$990M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.29% |
| 2 | Technology | 12.89% |
| 3 | Financials | 12.24% |
| 4 | Healthcare | 8.95% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3676
Seneca Foods Class A
SENEA
$1.2B
| $999K | ﹤0.01% |
32,068
-2,917
| -8% | -$84.1K |
2013 Q2
25 quarters
|
|
3677
CALL
Vipshop
VIPS
$5.92B
| $999K | ﹤0.01% |
+112,000
| New | +$916K |
2019 Q3
0 quarters
|
|
3678
KALA BIO
KALA
$8.11M
| $997K | ﹤0.01% |
105
+2
| +2% | +$24.3K |
2017 Q3
8 quarters
|
|
|
BFYT
3679
PUT
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $997K | ﹤0.01% |
40,000
-198,500
| -83% | -$4.17M |
2019 Q1
2 quarters
|
|
3680
Digimarc Corp
DMRC
$152M
| $995K | ﹤0.01% |
25,451
+22,310
| +710% | +$962K |
2017 Q4
7 quarters
|
|
3681
Puma Biotechnology
PBYI
$508M
| $995K | ﹤0.01% |
92,310
+255
| +0.3% | +$2.75K |
2013 Q2
25 quarters
|
|
3682
CytomX Therapeutics
CTMX
$573M
| $991K | ﹤0.01% |
134,262
+6,969
| +5% | +$68.7K |
2016 Q4
11 quarters
|
|
|
DENN
3683
DELISTED
Denny's
DENN
| $991K | ﹤0.01% |
43,463
+16,250
| +60% | +$364K |
2017 Q4
7 quarters
|
|
|
AXAS
3684
DELISTED
Abraxas Petroleum Corp
AXAS
| $991K | ﹤0.01% |
97,592
+807
| +0.8% | +$11.4K |
2016 Q4
11 quarters
|
|
3685
Park-Ohio Holdings
PKOH
$674M
| $989K | ﹤0.01% |
33,130
+1,334
| +4% | +$39.7K |
2013 Q2
25 quarters
|
|
3686
Orrstown Financial Services
ORRF
$807M
| $984K | ﹤0.01% |
44,879
+19,266
| +75% | +$420K |
2017 Q4
7 quarters
|
|
3687
iShares 10-20 Year Treasury Bond ETF
TLH
$10.4B
| $984K | ﹤0.01% |
6,580
+5,169
| +366% | +$760K |
2019 Q2
1 quarter
|
|
|
SJR
3688
CALL
DELISTED
Shaw Communications Inc.
SJR
| $983K | ﹤0.01% |
50,000
| – | – |
2018 Q4
3 quarters
|
|
|
BNY
3689
CALL
Bank of New York Mellon
BNY
$97.7B
| $981K | ﹤0.01% |
21,700
| – | – |
2017 Q3
8 quarters
|
|
|
SGMO
3690
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $980K | ﹤0.01% |
108,189
+8,166
| +8% | +$91.6K |
2016 Q4
11 quarters
|
|
|
HCR
3691
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $980K | ﹤0.01% |
+563,198
| New | +$1.08M |
2019 Q3
0 quarters
|
|
|
OIBR.C
3692
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
| $980K | ﹤0.01% |
890,606
-234,509
| -21% | -$366K |
2015 Q1
18 quarters
|
|
3693
Invesco BuyBack Achievers ETF
PKW
$1.69B
| $978K | ﹤0.01% |
15,629
-269
| -2% | -$16.8K |
2013 Q2
25 quarters
|
|
3694
CALL
Air Products & Chemicals
APD
$60.9B
| $976K | ﹤0.01% |
4,400
-2,100
| -32% | -$472K |
2017 Q3
8 quarters
|
|
3695
iShares MSCI Emerging Markets Asia ETF
EEMA
$893M
| $976K | ﹤0.01% |
15,300
| – | – |
2019 Q2
1 quarter
|
|
|
PGTI
3696
DELISTED
PGT, Inc.
PGTI
| $976K | ﹤0.01% |
56,560
-2,899
| -5% | -$45.6K |
2016 Q1
14 quarters
|
|
3697
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$2.8B
| $975K | ﹤0.01% |
19,224
-14,948
| -44% | -$759K |
2013 Q2
25 quarters
|
|
|
IBTX
3698
DELISTED
Independent Bank Group, Inc.
IBTX
| $974K | ﹤0.01% |
18,511
+8,553
| +86% | +$452K |
2017 Q4
7 quarters
|
|
3699
Natural Gas Services Group
NGS
$422M
| $971K | ﹤0.01% |
75,821
+35,865
| +90% | +$492K |
2016 Q4
11 quarters
|
|
|
I
3700
CALL
DELISTED
INTELSAT S. A.
I
| $969K | ﹤0.01% |
42,500
-115,700
| -73% | -$2.44M |
2018 Q3
4 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2019 Portfolio in Review
As of Q3 2019, JP Morgan Chase held 6,188 positions worth $502B, down 1.8% from $511B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q3 2019 filing shows 385 new, 2,786 increased, 1,863 reduced and 426 closed positions. Its largest new stake was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q3 2019 buy was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M.
- JP Morgan Chase added most to iShares 7-10 Year Treasury Bond ETF in Q3 2019, an estimated $2.01B increase.
- JP Morgan Chase's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
- JP Morgan Chase fully exited Worldpay, Inc. in Q3 2019, selling an estimated $372M.
- JP Morgan Chase's ten largest holdings make up 16% of its $502B portfolio in Q3 2019.
- JP Morgan Chase opened 385 new positions and closed 426 in Q3 2019.
- JP Morgan Chase's portfolio value fell 1.8% quarter-over-quarter to $502B.
Based on JP Morgan Chase's 13F filing for Q3 2019, filed 12 Nov 2019.